Depending on the stage, age, histological category, grade of tumor differentiation, status of the MYCN oncogene, chromosome 11q status, and DNA ploidy, NB can be categorized as low-, intermediate-, or high-risk according to the International Neuroblastoma Risk Group (INRG) [3]. This evidence concerns the gene MYCN and neuroblastoma.